MiR-142-3p as an Indicator of OSA Severity Predicts Prognosis in Lung Adenocarcinoma with OSA

References

• Hunyor I, Cook KM. Models of intermittent hypoxia and obstructive sleep apnea: molecular pathways and their contribution to cancer. Am J Physiol Regul Integr Comp Physiol. 2018;315(4):R669–r87. doi:10.1152/ajpregu.00036.2018
   PubMed Web of Science ®Google Scholar
• Torres G, Sánchez-de-la-Torre M, Barbé F. Relationship between OSA and hypertension. Chest. 2015;148(3):824–832. doi:10.1378/chest.15-0136
   PubMed Web of Science ®Google Scholar
• Gonzaga C, Bertolami A, Bertolami M, Amodeo C, Calhoun D. Obstructive sleep apnea, hypertension and cardiovascular diseases. J Hum Hypertens. 2015;29(12):705–712. doi:10.1038/jhh.2015.15
   PubMed Web of Science ®Google Scholar
• Lyons OD, Ryan CM. Sleep apnea and stroke. Can J Cardiol. 2015;31(7):918–927. doi:10.1016/j.cjca.2015.03.014
   PubMed Web of Science ®Google Scholar
• Kerner NA, Roose SP. Obstructive sleep apnea is linked to depression and cognitive impairment: evidence and potential mechanisms. Am J Geriatr Psychiatry. 2016;24(6):496–508. doi:10.1016/j.jagp.2016.01.134
   PubMed Web of Science ®Google Scholar
• Justeau G, Gervès-Pinquié C, Le Vaillant M, et al. Association between nocturnal hypoxemia and cancer incidence in patients investigated for OSA: data from a large multicenter French cohort. Chest. 2020;158(6):2610–2620. doi:10.1016/j.chest.2020.06.055
   PubMed Web of Science ®Google Scholar
• Huang HY, Lin SW, Chuang LP, et al. Severe OSA associated with higher risk of mortality in stage III and IV lung cancer. J Clin Sleep Med. 2020;16(7):1091–1098. doi:10.5664/jcsm.8432
   PubMed Web of Science ®Google Scholar
• Liu W, Zhou L, Zhao D, et al. Development and validation of a prognostic nomogram in lung cancer with obstructive sleep apnea syndrome. Front Med. 2022;9:810907. doi:10.3389/fmed.2022.810907
   Web of Science ®Google Scholar
• Yap DWT, Tan NKW, Tan BKJ, et al. The Association of obstructive sleep apnea with breast cancer incidence and mortality: a systematic review and meta-analysis. J Breast Cancer. 2022;2022:25.
   Google Scholar
• Choi JH, Lee JY, Han KD, Lim YC, Cho JH. Association between obstructive sleep apnoea and breast cancer: the Korean national health insurance service data 2007–2014. Sci Rep. 2019;9(1):19044. doi:10.1038/s41598-019-55551-7
   PubMed Web of Science ®Google Scholar
• Nieto FJ, Peppard PE, Young T, Finn L, Hla KM, Farré R. Sleep-disordered breathing and cancer mortality: results from the Wisconsin sleep cohort study. Am J Respir Crit Care Med. 2012;186(2):190–194. doi:10.1164/rccm.201201-0130OC
   PubMed Web of Science ®Google Scholar
• Hao S, Li F, Jiang P, Gao J. Effect of chronic intermittent hypoxia-induced HIF-1α/ATAD2 expression on lung cancer stemness. Cell Mol Biol Lett. 2022;27(1):44. doi:10.1186/s11658-022-00345-5
   PubMed Web of Science ®Google Scholar
• de Heer EC, Jalving M, Harris AL. HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer. J Clin Invest. 2020;130(10):5074–5087. doi:10.1172/JCI137552
   PubMed Web of Science ®Google Scholar
• Liu J, Gao L, Zhan N, et al. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma. J Exp Clin Cancer Res. 2020;39(1):137. doi:10.1186/s13046-020-01641-8
   PubMed Web of Science ®Google Scholar
• Saatci O, Kaymak A, Raza U, et al. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nat Commun. 2020;11(1):2416. doi:10.1038/s41467-020-16199-4
   PubMed Web of Science ®Google Scholar
• Jin C, Xiao L, Zhou Z, Zhu Y, Tian G, Ren S. MiR-142-3p suppresses the proliferation, migration and invasion through inhibition of NR2F6 in lung adenocarcinoma. Hum Cell. 2019;32(4):437–446. doi:10.1007/s13577-019-00258-0
   PubMed Web of Science ®Google Scholar
• Liu J, Tian W, Zhang W, et al. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression. Biomed Pharmacother. 2019;114:108847. doi:10.1016/j.biopha.2019.108847
   PubMed Web of Science ®Google Scholar
• Rami-Porta R, Asamura H, Travis WD, Rusch VW. Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):138–155. doi:10.3322/caac.21390
   PubMed Web of Science ®Google Scholar
• Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387–1394. doi:10.1378/chest.14-0970
   PubMed Web of Science ®Google Scholar
• Huang HY, Shih-Wei L, Chuang LP, et al. Severe obstructive sleep apnea associated with higher risk of mortality in stage III and IV lung cancer. J Clin Sleep Med. 2020;2020:1.
   Google Scholar
• Cheng L, Guo H, Zhang Z, Yao Y, Yao Q. Obstructive sleep apnea and incidence of malignant tumors: a meta-analysis. Sleep Med. 2021;84:195–204. doi:10.1016/j.sleep.2021.05.029
   PubMed Web of Science ®Google Scholar
• Martínez-García M, Campos-Rodriguez F, Barbé F. Cancer and OSA: current evidence from human studies. Chest. 2016;150(2):451–463. doi:10.1016/j.chest.2016.04.029
   PubMed Web of Science ®Google Scholar
• Campos-Rodriguez F, Martinez-Garcia MA, Martinez M, et al. Association between obstructive sleep apnea and cancer incidence in a large multicenter Spanish cohort. Am J Respir Crit Care Med. 2013;187(1):99–105. doi:10.1164/rccm.201209-1671OC
   PubMed Web of Science ®Google Scholar
• Xiong H, Lao M, Zhang S, et al. A cross-sectional study of obstructive sleep apnea in patients with colorectal cancer. J Gastrointest Oncol. 2022;13(2):683–694. doi:10.21037/jgo-22-175
   PubMed Web of Science ®Google Scholar
• Gu X, Zhang J, Shi Y, et al. ESM1/HIF‑1α pathway modulates chronic intermittent hypoxia‑induced non‑small‑cell lung cancer proliferation, stemness and epithelial‑mesenchymal transition. Oncol Rep. 2021;45(3):1226–1234. doi:10.3892/or.2020.7913
   PubMed Web of Science ®Google Scholar
• Hao S, Zhu X, Liu Z, et al. Chronic intermittent hypoxia promoted lung cancer stem cell-like properties via enhancing Bach1 expression. Respir Res. 2021;22(1):58. doi:10.1186/s12931-021-01655-6
   PubMed Web of Science ®Google Scholar
• Chao Y, Shang J, Ji W. ALKBH5-m(6)A-FOXM1 signaling axis promotes proliferation and invasion of lung adenocarcinoma cells under intermittent hypoxia. Biochem Biophys Res Commun. 2020;521(2):499–506. doi:10.1016/j.bbrc.2019.10.145
   PubMed Web of Science ®Google Scholar
• Li W, Huang K, Wen F, et al. Intermittent hypoxia-induced downregulation of microRNA-320b promotes lung cancer tumorigenesis by increasing CDT1 via USP37. Mol Ther Nucleic Acids. 2021;24:528–541. doi:10.1016/j.omtn.2020.12.023
   PubMedGoogle Scholar
• Kang HS, Kwon HY, Kim IK, et al. Intermittent hypoxia exacerbates tumor progression in a mouse model of lung cancer. Sci Rep. 2020;10(1):1854. doi:10.1038/s41598-020-58906-7
   PubMed Web of Science ®Google Scholar
• Almendros I, Wang Y, Becker L, et al. Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea. Am J Respir Crit Care Med. 2014;189(5):593–601. doi:10.1164/rccm.201310-1830OC
   PubMed Web of Science ®Google Scholar
• Hou P, Shi P, Jiang T, et al. DKC1 enhances angiogenesis by promoting HIF-1α transcription and facilitates metastasis in colorectal cancer. Br J Cancer. 2020;122(5):668–679. doi:10.1038/s41416-019-0695-z
   PubMed Web of Science ®Google Scholar
• Jögi A, Ehinger A, Hartman L, Alkner S. Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer. PLoS One. 2019;14(12):e0226150. doi:10.1371/journal.pone.0226150
   PubMed Web of Science ®Google Scholar
• Ou ZL, Zhang M, Ji LD, et al. Long noncoding RNA FEZF1-AS1 predicts poor prognosis and modulates pancreatic cancer cell proliferation and invasion through miR-142/HIF-1α and miR-133a/EGFR upon hypoxia/normoxia. J Cell Physiol. 2019;234:15407–15419. doi:10.1002/jcp.28188
   PubMed Web of Science ®Google Scholar
• Li M, Li BY, Xia H, Jiang LL. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis. Eur Rev Med Pharmacol Sci. 2017;21(10):2346–2350.
   PubMed Web of Science ®Google Scholar
• Tembe V, Schramm SJ, Stark MS, et al. MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis. Pigment Cell Melanoma Res. 2015;28(3):254–266. doi:10.1111/pcmr.12343
   PubMed Web of Science ®Google Scholar